je.st
news
Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea
2015-02-10 19:47:44| Chemicals - Topix.net
Reporting before the open, Regeneron logged fourth-quarter revenue of $802.3 million, up 31% from the prior year and above consensus analyst views of $781.5 million. On the downside, adjusted earnings fell below estimates at $2.79 a share - three cents below the consenus of Thomson Reuters.
Tags: sales
outlook
upbeat
regeneron
Category:Chemicals